Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Revenue

In the fiscal year ending March 31, 2026, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 62.31B JPY with 2.88% growth. Fuso Pharmaceutical Industries,Ltd. had revenue of 14.04B in the quarter ending March 31, 2026, a decrease of -17.01%.

• Revenue: 62.31B
• Revenue Growth: +2.88%
• P/S Ratio: 0.30
• Revenue / Employee: 45.48M
• Employees: 1,370
• Market Cap: 18.51B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	62.31B	1.74B	2.88%
Mar 31, 2025	60.56B	5.16B	9.31%
Mar 31, 2024	55.41B	6.80B	13.98%
Mar 31, 2013	48.61B	4.25B	9.59%
Mar 31, 2012	44.36B	-3.11B	-6.55%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error